Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis

NCT02848625 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-01-31

No results posted yet for this study

Summary

This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting of the COVID Pandemic.

Conditions

Interventions

OTHER

Yoga

Yoga and breathing exercises designed for patients with IPF. Sessions will be two times per week for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Ganesh Raghu, MD · University of Washington, Center for Interstitial Lung Diseases

  • Bridget F Collins, MD · University of Washington, Center for Interstitial Lung Diseases

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02848625 on ClinicalTrials.gov